Allakos Inc. (ALLK)
NASDAQ: ALLK · IEX Real-Time Price · USD
1.070
+0.010 (0.94%)
Apr 18, 2024, 11:54 AM EDT - Market open
Allakos Market Cap
Allakos has a market cap or net worth of $94.46 million as of April 18, 2024. Its market cap has decreased by -74.48% in one year.
Market Cap
94.46M
Enterprise Value
-38.11M
1-Year Change
-74.48%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since July 19, 2018, Allakos's market cap has decreased from $1.24B to $94.46M, a decrease of -92.39%. That is a compound annual growth rate of -36.10%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2024 | 93.10M | 0.87% |
Apr 16, 2024 | 92.30M | -2.74% |
Apr 15, 2024 | 94.90M | -2.67% |
Apr 12, 2024 | 97.50M | -8.28% |
Apr 11, 2024 | 106.30M | 4.32% |
Apr 10, 2024 | 101.90M | -3.32% |
Apr 9, 2024 | 105.40M | 6.14% |
Apr 8, 2024 | 99.30M | -5.07% |
Apr 5, 2024 | 104.60M | -3.24% |
Apr 4, 2024 | 108.10M | -3.91% |
Apr 3, 2024 | 112.50M | 3.21% |
Apr 2, 2024 | 109.00M | 1.68% |
Apr 1, 2024 | 107.20M | -3.16% |
Mar 28, 2024 | 110.70M | -1.60% |
Mar 27, 2024 | 112.50M | -0.79% |
Mar 26, 2024 | 113.40M | -2.24% |
Mar 25, 2024 | 116.00M | -2.19% |
Mar 22, 2024 | 118.60M | 4.59% |
Mar 21, 2024 | 113.40M | -1.48% |
Mar 20, 2024 | 115.10M | 4.83% |
Mar 19, 2024 | 109.80M | 1.57% |
Mar 18, 2024 | 108.10M | -6.08% |
Mar 15, 2024 | 115.10M | 0.35% |
Mar 14, 2024 | 114.70M | -5.98% |
Mar 13, 2024 | 122.00M | 4.90% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Aurora Cannabis | 98.76M |
Oramed Pharmaceuticals | 98.06M |
Reviva Pharmaceuticals Holdings | 97.16M |
KORU Medical Systems | 96.87M |
Clearside Biomedical | 96.39M |
Elicio Therapeutics | 94.34M |
Seres Therapeutics | 93.31M |
Milestone Pharmaceuticals | 93.28M |